Erasca Inc. is a pioneering biotechnology company dedicated to discovering and developing precision medicines to erase cancer. With a focus on drugging “undruggable” oncogenic targets, Erasca aims to revolutionize cancer care and improve patient outcomes. Their cutting-edge approach combines innovative target identification and drug development strategies to tackle some of the greatest challenges in cancer research.
Notification